Nanoparticles loaded with bee venom kill HIV
(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of ...
HIV & AIDS
Mar 08, 2013 |
5 / 5 (29) |
3
|
Revealed: Secret of HIV's natural born killers
Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.
HIV & AIDS
Jun 10, 2012 |
4.6 / 5 (17) |
1
Indian drug giant Cipla slashes cancer drug prices
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
Medications
May 04, 2012 |
4.9 / 5 (9) |
0
Drug helps purge hidden HIV virus, study shows
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.
HIV & AIDS
Mar 08, 2012 |
4.8 / 5 (5) |
0
Protein discovery could lead to new HIV drugs
(Medical Xpress) -- A team of researchers at the Johns Hopkins Bloomberg School of Public Health recently discovered a new protein that enables HIV to destroy human cells. The finding provides scientists with ...
HIV & AIDS
Jan 27, 2012 |
4.8 / 5 (4) |
1
|
Changing the locks: HIV discovery could allow scientists to block virus's entry into cell nucleus
Scientists have found the 'key' that HIV uses to enter our cells' nuclei, allowing it to disable the immune system and cause AIDS The finding, published today in the open access journal PLoS Pathogens, provides a potential new ta ...
HIV & AIDS
Dec 08, 2011 |
5 / 5 (3) |
0
|
HIV/AIDS vaccine developed at Western proceeding to human clinical trials
The first and only preventative HIV vaccine based on a genetically modified killed whole virus has received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.
HIV & AIDS
Dec 20, 2011 |
5 / 5 (3) |
0
HIV prevention research named scientific breakthrough of the year by Science
The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science.
HIV & AIDS
Dec 22, 2011 |
5 / 5 (3) |
3
|
Pioneering research shows drug can purge dormant HIV
Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment ...
HIV & AIDS
Jul 25, 2012 |
5 / 5 (3) |
0
|
Anti-HIV vaginal ring can prevent virus transmission: animal study
Population Council scientists have found that a vaginal ring releasing an anti-HIV drug can prevent the transmission of SHIV in macaques. This study provides the first efficacy data on the delivery of a microbicide from a ...
HIV & AIDS
Sep 05, 2012 |
5 / 5 (3) |
0
|
Double duty: Anti-HIV topical gel also protects against herpes virus
HIV infection is commonly associated with other sexual infections, such as herpes simplex virus (HSV). Infection with HSV facilitates the risk of HIV infection and negatively impacts the clinical course of HIV disease. Therefore, ...
HIV & AIDS
Oct 19, 2011 |
3.7 / 5 (3) |
0
Electrically spun fabric offers dual defense against pregnancy, HIV
The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations.
HIV & AIDS
Nov 30, 2012 |
3.7 / 5 (3) |
0
|
Vaccination strategy may hold key to ridding HIV infection from immune system
Using human immune system cells in the lab, AIDS experts at Johns Hopkins have figured out a way to kill off latent forms of HIV that hide in infected T cells long after antiretroviral therapy has successfully stalled viral ...
Immunology
Mar 08, 2012 |
5 / 5 (2) |
0
|
New data suggests HIV superinfection rate comparable to initial HIV infection
HIV superinfection, when a person with HIV could acquire a second, new strain of HIV, may occur as often as initial HIV infection in the general population in Uganda, a study suggests.
HIV & AIDS
Jun 07, 2012 |
5 / 5 (2) |
0
|
Potent antibodies neutralize HIV and could offer new therapy, study finds
(Medical Xpress)—Having HIV/AIDS is no longer a death sentence, but it's still a lifelong illness that requires an expensive daily cocktail of drugs—and it means tolerating those drugs' side effects and ...
Immunology
Nov 07, 2012 |
5 / 5 (2) |
0
|
